Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is Logos Global Management LP's Largest Position

Logos Global Management LP cut its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 40.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 800,000 shares of the company’s stock after selling 550,000 shares during the period. Apellis Pharmaceuticals accounts for approximately […]

Related Keywords

United States ,America ,Davido Watson ,Cedric Francois ,Blackrock Inc ,T Rowe Price Investment Management Inc ,Apellis Pharmaceuticals Company Profile ,Needham Company ,Vanguard Group Inc ,Nasdaq ,Exchange Commission ,News Ratings For Apellis Pharmaceuticals Daily ,Wells Fargo Company ,Apellis Pharmaceuticals ,Citigroup ,Apellis Pharmaceuticals Inc ,Apellis Pharmaceuticals Stock Performance ,Avoro Capital Advisors ,Insider Activity At Apellis Pharmaceuticals ,Quarter For Apellis Pharmaceuticals ,Logos Global Management ,Free Report ,Global Management ,Capital Advisors ,Rowe Price Investment Management ,General Counsel David ,Get Free Report ,Wells Fargo ,Visit Holdingschannel ,Apellis Pharmaceuticals Daily ,Nasdaq Apls ,Apls ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,